Wilke, R A <br/><br/>
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jul 2012 
 - 112-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2012.57  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Prescriptions<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Liver-Specific Organic Anion Transporter 1<br/>Muscular Diseases--chemically induced<br/>Organic Anion Transporters--genetics<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Precision Medicine<br/>Risk Assessment<br/>Risk Factors<br/>Simvastatin--administration & dosage